Needham analyst Ami Fadia reaffirmed a Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and raised the price target ...

The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...

Anne E Borgman currently works at NextCure, Inc., as Independent Director from 2021, NiKang Therapeutics, Inc., as Director from 2023, Curis, Inc., as Independent Director from 2022, and Sutro ...

What is a Yearly Growth Rate? The Yearly Growth Rate chart for Jazz Pharma (JAZZ) compares annual sales cycles. Purposefully, companies prefer to measure earnings progress based on annual sales trends ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: Jefferies Global ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: ...

Fireside chat at 7:00 a.m. PDT / 10:00 a.m. EDT / 3:00 p.m. IST Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at https ...

For each €0.10 of cash received one private non-tradable warrant to purchase one share, subject to the adjustment below, will be issued with an exercise price of €0.10. Maturity of the ...

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a ...